By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Discovery, development and commercialization of messenger RNA medicines17.15M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States152.31M100.00%